2Suppliers
1Customers
3Debt Items
20Related Chains

Foghorn Therapeutics Inc. Suppliers

TickerNameConfidenceEvidence
LLY Eli Lilly and Company 90% Concurrent with the Lilly Collaboration Agreement, we also entered into a stock purchase agreement (the "Lilly SPA") with Lilly whereby we issued and sold Lilly 4,000,000 shares of our common stock, …
LLY Eli Lilly and Company 90% Reciprocal relationship from LLY graph: Reciprocal relationship from FHTX graph: Concurrent with the Lilly Collaboration Agreement, we also entered into a stock purchase agreement (the "Lilly SPA") w…

Foghorn Therapeutics Inc. Customers

TickerNameConfidenceEvidence
LILLY LILLY 92% Lilly is a leading oncology company with a track record of innovation and execution

Foghorn Therapeutics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
FHTX-DEBT-9496 Warrants outstanding: 114000 90% xbrl warrant detail from xbrl 2021-12-31.
FHTX-DEBT-9497 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
FHTX-DEBT Debt stack $42.0M 90% Market cache reports total debt of $42.0M.

Foghorn Therapeutics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Foghorn Therapeutics Inc..

Foghorn Therapeutics Inc. Ownership

HolderNameConfidenceEvidence
FHTX-OWNER-FLAGSHIP-PIONEERING-LLC Flagship Pioneering, LLC 90% 13F overlay lists Flagship Pioneering, LLC as top holder; 105 tracked holders.

Foghorn Therapeutics Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CRIS Curis, Inc. 100.00 2
IMNM Immunome, Inc. 100.00 2
ACIU AC Immune SA 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2
VEEV Veeva Systems Inc. 100.00 2
VNDA Vanda Pharmaceuticals Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
BYSI BeyondSpring Inc. 100.00 2
ACRS Aclaris Therapeutics, Inc. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
ALEC Alector, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
VIVS VivoSim Labs, Inc. 100.00 2